Ownership history in CM Management, LLC · 21 quarters on record
This page tracks every 13F SEC filing in which CM Management, LLC reported a position in HERON THERAPEUTICS INC (HRTX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | UNCHANGED | 750,000 | — | 0% | 0.82% | $975K | $1.30 |
| 2025 Q3 | ADDED | 750,000 | +150,000 | +25.0% | 0.79% | $945K | $1.26 |
| 2025 Q2 | UNCHANGED | 600,000 | — | 0% | 1.13% | $1.2M | $2.07 |
| 2025 Q1 | REDUCED | 600,000 | -100,000 | -14.3% | 1.33% | $1.3M | $2.20 |
| 2024 Q4 | ADDED | 700,000 | +200,000 | +40.0% | 0.96% | $1.1M | $1.53 |
| 2024 Q3 | ADDED | 500,000 | +200,000 | +66.7% | 0.79% | $995K | $1.99 |
| 2024 Q2 | UNCHANGED | 300,000 | — | 0% | 0.96% | $1.1M | $3.50 |
| 2024 Q1 | REDUCED | 300,000 | -25,000 | -7.7% | 0.70% | $831K | $2.77 |
| 2023 Q4 | REDUCED | 325,000 | -125,000 | -27.8% | 0.44% | $552K | $1.70 |
| 2023 Q3 | REDUCED | 450,000 | -50,000 | -10.0% | 0.49% | $464K | $1.03 |
As of 2025 Q4 — sorted by position size